Elimination of oral foci of infection might lead to clinical improvement of Graves' orbitopathy. [PDF]
Sawicka-Gutaj N +6 more
europepmc +1 more source
Ocular surface disease index in Graves' orbitopathy: a cross-sectional study. [PDF]
Maglionico MN +7 more
europepmc +1 more source
Impact of ibrutinib on inflammation in a mouse model of Graves' orbitopathy. [PDF]
Kim C +8 more
europepmc +1 more source
Combining orbital intensity modulated radiation therapy with periorbital triamcinolone acetonide injection for Graves' orbitopathy. [PDF]
Jian H, Ma RX, He WM.
europepmc +1 more source
Butyrate Ameliorates Graves' Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota. [PDF]
Ouyang P +7 more
europepmc +1 more source
Predictive modeling of graves' orbitopathy activity based on meibomian glands analysis using in vivo confocal microscopy. [PDF]
Su Z +6 more
europepmc +1 more source
PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy. [PDF]
Peng Z +12 more
europepmc +1 more source
Association of Lower Alanine Transaminase (ALT) and Aspartate Aminotransferase (AST) Levels With Eyelid Edema in Graves' Orbitopathy: A Retrospective Cross-Sectional Study. [PDF]
Xiang Y +5 more
europepmc +1 more source
Canonical and Truncated Transglutaminase-2 Drive TGF-β1 Autocrine Loop to Induce Fibrosis in Graves' Orbitopathy. [PDF]
Bao X +7 more
europepmc +1 more source

